Department of Gynaecology, Odense University Hospital, Denmark; Department of Gynaecology, Copenhagen University Hospital, Rigshospitalet, Denmark.
Department of Gynaecology, Copenhagen University Hospital, Rigshospitalet, Denmark.
Gynecol Oncol. 2022 Jun;165(3):420-427. doi: 10.1016/j.ygyno.2022.04.009. Epub 2022 Apr 26.
A combination of tumour size, differentiation grade and location may identify a group of vulvar squamous cell cancer (VSCC) patients with a very low risk of inguinal lymph node metastasis. We aim to examine these findings in a large national cohort of VSCC patients.
Population based prospective data on VSCC patients treated with vulvectomy and primary groin surgery was obtained from the Danish Gynaecological Cancer Database. Univariate chi-square and multivariate logistic regression analysis were used. Statistical tests were 2-sided. P-values of <0.05 were considered statistically significant.
In all, 388 VSCC patients were identified. Of these 264 (63.3%) were node negative and 121 (36.7%) node positive. Increasing tumour size (diameter ≤ 2 cm vs. > 2 to 4 cm), grade (1 vs. 2-3) and location of tumour to clitoris were all associated with a significantly increased risk of inguinal lymph node metastasis OR 2.81(95% CI 1.52-5.20), OR 3.19 (95% CI 1.77-5.74) and OR 2.74 (95% CI 1.56-5.20), respectively. Previous vulvar disease was not associated with lymph node metastasis. No lymph node metastasis was demonstrated in patients with grade 1 tumours, tumour size less than 2 cm and located outside the clitoris area (n = 51).
VSCC patients with grade 1 tumours, ≤ 2 cm and without clitoral involvement have a very low risk of inguinal lymph node metastasis. These patients may be spared inguinal lymph node staging to decrease operating time and peri- and postoperative morbidity in the future. However, studies validating our findings are needed.
肿瘤大小、分化程度和位置的组合可能确定一组外阴鳞癌(VSCC)患者,其腹股沟淋巴结转移的风险非常低。我们旨在对大量 VSCC 患者进行研究。
从丹麦妇科癌症数据库中获得了接受外阴切除术和原发性腹股沟手术治疗的 VSCC 患者的基于人群的前瞻性数据。使用单变量卡方检验和多变量逻辑回归分析。统计检验为双侧。P 值<0.05 被认为具有统计学意义。
共确定了 388 例 VSCC 患者。其中 264 例(63.3%)为淋巴结阴性,121 例(36.7%)为淋巴结阳性。肿瘤大小(直径≤2cm 与>2 至 4cm)、分级(1 级与 2-3 级)和肿瘤位于阴蒂的位置均与腹股沟淋巴结转移的风险显著增加相关,OR 值分别为 2.81(95%CI 1.52-5.20)、3.19(95%CI 1.77-5.74)和 2.74(95%CI 1.56-5.20)。先前的外阴疾病与淋巴结转移无关。在肿瘤分级为 1 级、肿瘤大小小于 2cm 且位于阴蒂区域外的患者(n=51)中未发现淋巴结转移。
肿瘤分级为 1 级、肿瘤大小≤2cm 且无阴蒂受累的 VSCC 患者腹股沟淋巴结转移的风险非常低。这些患者可能免于进行腹股沟淋巴结分期,以减少未来手术时间和围手术期发病率。然而,需要验证我们发现的研究。